Molecular characteristics of outbreaks of nosocomial infection with influenza A/H3N2 virus variants

Infection Control and Hospital Epidemiology

Volumn 32, Issue 3, 2011, Pages 267-275

  Oguma, Taeko ^a   Saito, Reiko ^a   Masaki, Hironori ^b   Hoshino, Kazuhiko ^c   Zaraket, Hassan ^a,h   Suzuki, Yasushi ^a   Caperig Dapat, Isolde ^a   Dapat, Clyde ^a   Baranovich, Tatiana ^a   Kuroki, Reiki ^c   Makimoto, Yasushi ^c   Shirahige, Yutaka ^d   Asoh, Norichika ^e   Degawa, Satoshi ^f   Ishikawa, Hidefumi ^d   Kageura, Hironobu ^g   Hosoi, Maki ^a   Suzuki, Hiroshi ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b Masaki Clinic   (Japan)

^c Tagami Hospital   (Japan)

^d Nagasaki Doctors' Network for Home Medical Care   (Japan)

^e Juzenkai Hopital   (Japan)

^f Aino Memorial Hospital   (Japan)

^g Kageura Clinic   (Japan)

^h ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; HEMAGGLUTININ; OSELTAMIVIR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; EPIDEMIC; FEMALE; GENOTYPE; HEALTH CARE PERSONNEL; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INFLUENZA A (H3N2); INFLUENZA VIRUS A H3N2; JAPAN; MALE; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; RETROSPECTIVE STUDY; VIRUS STRAIN;

ADULT; AGED; AGED, 80 AND OVER; BACTERIAL TYPING TECHNIQUES; CROSS INFECTION; DISEASE OUTBREAKS; DISEASE TRANSMISSION, INFECTIOUS; FEMALE; HEMAGGLUTININS, VIRAL; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; JAPAN; MALE; MIDDLE AGED; PHYLOGENY; RETROSPECTIVE STUDIES; RNA, VIRAL; SEQUENCE ANALYSIS, RNA;

EID: 79952379058     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/658671     Document Type: Article

References (31)

1. Maltezou HC. Nosocomial influenza: new concepts and practice. Curr Opin Infect Dis 2008;21:337-343.
2. Salgado CD, Farr BM, Hall KK, Hayden FG. Influenza in the acute hospital setting. Lancet Infect Dis 2002;2:145-155.
3. Gooskens J, Jonges M, Claas E, Meijer A, van den Broek P, Kroes A. Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenza A(H1N1) virus. JAMA 2009;301:1042-1046.
4. Young LC, Dwyer DE, Harris M, Guse Z, Noel V, Levy MH. Summer outbreak of respiratory disease in an Australian prison due to an influenza A/Fujian/411/2002(H3N2)-like virus. Epidemiol Infect 2005;133:107-112.
5. Awofeso N, Fennell M,Waliuzzaman Z, et al. Influenza outbreak in a correctional facility. Aust N Z J Public Health 2001;25:443-446.
6. Centers for Disease Control and Prevention. Influenza B virus outbreak on a cruise ship: Northern Europe, 2000. MMWR Morb Mortal Wkly Rep 2001;50:137-140.
7. Liu P, Wang L, Lin Y, Tsai C, Shi Z. Outbreak of influenza A and B among military recruits: evidence from viral culture and polymerase chain reaction. J Microbiol Immunol Infect 2009;42:114-121.
8. Balicer R, Huerta M, Levy Y, Davidovitch N, Grotto I. Influenza outbreak control in confined settings. Emerg Infect Dis 2005;11:579-583. (Pubitemid 40462908)
9. D'Agaro P, Rossi T, Burgnich P, et al. The molecular epidemiology of influenza viruses: a lesson from a highly epidemic season. J Clin Pathol 2008;61:355-360. (Pubitemid 351354245)
10. Gubareva LV, Novikov DV, Hayden FG. Assessment of hemagglutinin sequence heterogeneity during influenza virus transmission in families. J Infect Dis 2002;186:1575-1581. (Pubitemid 35379633)
11. Teo S, Ellis J, Aitken C, Booy R. Transmission of influenza A in families. Pediatr Infect Dis J 2007;26:645-647.
12. Saito R, Suzuki Y, Li D, et al. Increased incidence of adamantane-resistant influenza A(H1N1) and A(H3N2) viruses during the 2006-2007 influenza season in Japan. J Infect Dis 2008;197:630-632; author reply 632-633.
13. Saito R, Li D, Suzuki Y, et al. High prevalence of amantadine-resistance influenza A(H3N2) in six prefectures, Japan, in the 2005-2006 season. J Med Virol 2007;79:1569-1576. (Pubitemid 47328746)
14. Suzuki Y, Saito R, Zaraket H, et al. Rapid and specific detection of amantadine-resistant Ser31As1 mutated influenza A viruses by cycling probe method: detection of amantadine-resistant influenza A. J Clin Microbiol 2010;48:57-63.
15. Hara M, Takao S, Fukuda S, Shimazu Y, Kuwayama M, Miyazaki K. Comparison of four rapid diagnostic kits using immunochromatography to detect influenza B viruses [in Japanese]. Kansenshogaku Zasshi 2005;79:803-811.
16. Hota S, McGeer A. Antivirals and the control of influenza outbreaks. Clin Infect Dis 2007;45:1362-1368.
17. Hoffmann E, Stech J, Guan Y, Webster R, Perez D. Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol 2001;146:2275-2289. (Pubitemid 34682391)
18. Besselaar TG, Botha L, McAnerney JM, Schoub BD. Antigenic and molecular analysis of influenza A(H3N2) virus strains isolated from a localised influenza outbreak in South Africa in 2003. J Med Virol 2004;73:71-78. (Pubitemid 38429150)
19. Zaraket H, Saito R, Sato I, et al. Molecular evolution of human influenza A viruses in a local area during eight influenza epidemics from 2000 to 2007. Arch Virol 2009;154:285-295.
20. Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 1999;41:95-98.
21. Kumar S, Tamura K, Nei M. MEGA3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform 2004;5:150-163.
22. Bao Y, Bolotov P, Dernovoy D, et al. The influenza virus resource at the National Center for Biotechnology Information. J Virol 2008;82:596-601.
23. Infectious Disease Surveillance Center, National Institute of Infectious Diseases. 2006/07 Influenza season, Japan. Infectious Agents Surveillance Report (IASR) 2007;28:311-313. http://idsc.nih.go.jp/iasr/28/333/dj3331.html.
24. Hirano K, Hara M. Virus isolation on surveillance of infection disease (2006) [in Japanese]. Nagasaki Prefect Inst Environ Res Public Health 2007;53.
25. Lee N, Chan P, Hui D, et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis 2009;200:492-500.
26. Babcock HM, Merz LR, Fraser VJ. Is influenza an influenza-like illness? clinical presentation of influenza in hospitalized patients. Infect Control Hosp Epidemiol 2006;27:266-270.
27. van den Dool C, Hak E, Wallinga J, van Loon A, Lammers J, Bonten M. Symptoms of influenza virus infection in hospitalized patients. Infect Control Hosp Epidemiol 2008;29:314-319. (Pubitemid 351416981)
28. Fiore A, Shay D, Broder K, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep 2008;57(RR-7):1-60.
29. Oshitani H, Saito R, Seki N, et al. Influenza vaccination levels and influenza-like illness in long-term-care facilities for elderly people in Niigata, Japan, during an influenza A(H3N2) epidemic. Infect Control Hosp Epidemiol 2000;21:728-730.
30. Saito R, Suzuki H, Oshitani H, Sakai T, Seki N, Tanabe N. The effectiveness of influenza vaccine against influenza A(H3N2) virus infections in nursing homes in Niigata, Japan, during the 1998-1999 and 1999-2000 seasons. Infect Control Hosp Epidemiol 2002;23:82-86.
31. Shugarman L, Hales C, Setodji C, Bardenheier B, Lynn J. The influence of staff and resident immunization rates on influenzalike illness outbreaks in nursing homes. J Am Med Dir Assoc 2006;7:562-567. (Pubitemid 44667893)